Investors in Nutex Corporation are reminded of the approaching Class Action Lawsuit, with the lead plaintiff deadline set for October 21, 2025. This notice comes from Faruqi & Faruqi.

In a significant development, Nutex Health Inc. is currently under investigation by the leading national securities law firm, Faruqi & Faruqi, LLP. The investigation was initiated by the law firm itself, representing investors who have suffered losses.

The allegations against Nutex Health include overstating its ability to remediate material weaknesses in its internal controls over financial reporting. This, in turn, increased the risk that Nutex would be unable to timely file certain financial reports with the United States Securities and Exchange Commission.

Moreover, the complaint alleges that Nutex improperly calculated certain stock-based compensation obligations as equity rather than liabilities. It also accuses the company of overstating its revenues from its engagement with HaloMD, a third-party vendor.

These allegations have led to a delay in filing Nutex Health's Form 10-Q for the period ending June 30, 2025. The company cited non-cash accounting adjustments related to stock-based compensation obligations as the reason for the delay. However, the investigation suggests that the real cause may be more complex.

On July 22, 2025, a short report by Blue Orca Capital accused Nutex of facing litigation risk due to its relationship with HaloMD, which is alleged to have engaged in a coordinated scheme to defraud insurance companies.

In response to these allegations, Nutex Health announced that the delay in filing its Form 10-Q was due to under-construction and ramping hospitals. However, the investigation is ongoing, and further details are yet to be disclosed.

For investors who wish to seek the role of lead plaintiff in the federal securities class action against Nutex, the deadline is October 21, 2025. Interested parties can learn more about the Nutex Health class action at www.faruqilaw.com/NUTX or by contacting Faruqi & Faruqi partner Josh Wilson directly.

Anyone with information regarding Nutex's conduct is encouraged to contact Faruqi & Faruqi, LLP, including whistleblowers, former employees, shareholders, and others. The law firm can be reached at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP also encourages following them for updates on LinkedIn, X, or Facebook. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

The stock price of Nutex Health fell $18.22 per share, or 16.39%, after the market closed on August 15, 2025, following the release of these allegations. The investigation continues, and updates will be provided as more information becomes available.